Published in Antimicrob Agents Chemother on June 01, 2002
Adding selectivity to antimicrobial peptides: rational design of a multidomain peptide against Pseudomonas spp. Antimicrob Agents Chemother (2006) 1.17
Host defense peptides in wound healing. Mol Med (2008) 1.10
Enhanced susceptibility to infections in a diabetic wound healing model. BMC Surg (2008) 1.09
Host defense peptides as effector molecules of the innate immune response: a sledgehammer for drug resistance? Int J Mol Sci (2009) 1.08
Animal models of external traumatic wound infections. Virulence (2011) 1.07
Inhibition of early steps in the lentiviral replication cycle by cathelicidin host defense peptides. Retrovirology (2005) 1.07
Enhancement of antimicrobial activity against pseudomonas aeruginosa by coadministration of G10KHc and tobramycin. Antimicrob Agents Chemother (2006) 1.03
Antimicrobial peptides effectively kill a broad spectrum of Listeria monocytogenes and Staphylococcus aureus strains independently of origin, sub-type, or virulence factor expression. BMC Microbiol (2008) 0.98
Adenoviral gene delivery to primary human cutaneous cells and burn wounds. Mol Med (2007) 0.93
Antimicrobial peptide killing of African trypanosomes. Parasite Immunol (2011) 0.92
Topical nanoemulsion therapy reduces bacterial wound infection and inflammation after burn injury. Surgery (2010) 0.92
Different anti-Candida activities of two human lactoferrin-derived peptides, Lfpep and kaliocin-1. Antimicrob Agents Chemother (2005) 0.88
Effects of intratracheal administration of novispirin G10 on a rat model of mucoid Pseudomonas aeruginosa lung infection. Antimicrob Agents Chemother (2005) 0.83
Novispirin G10-induced lung toxicity in a Klebsiella pneumoniae infection model. Antimicrob Agents Chemother (2003) 0.83
Efficacy of topically delivered moxifloxacin against wound infection by Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (2011) 0.81
Topical antimicrobials for burn infections - an update. Recent Pat Antiinfect Drug Discov (2013) 0.80
Bioengineered human skin: working the bugs out. Mol Ther (2009) 0.79
Burn wounds infected with Pseudomonas aeruginosa triggers weight loss in rats. BMC Surg (2005) 0.77
Antiseptics in surgery. Eplasty (2010) 0.75
The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest (2000) 9.51
The successful control of burn wound sepsis. J Trauma (1965) 3.43
Protegrins: leukocyte antimicrobial peptides that combine features of corticostatic defensins and tachyplesins. FEBS Lett (1993) 3.30
Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain. FEBS Lett (1995) 3.21
Protegrin-1: a broad-spectrum, rapidly microbicidal peptide with in vivo activity. Antimicrob Agents Chemother (1997) 3.12
Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa. Arch Intern Med (1999) 3.08
Antibacterial action of structurally diverse cationic peptides on gram-positive bacteria. Antimicrob Agents Chemother (2000) 3.06
Antimicrobial peptides in mammalian and insect host defence. Curr Opin Immunol (1999) 3.05
FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis. Proc Natl Acad Sci U S A (1995) 2.89
A standard animal burn. J Trauma (1968) 2.82
Control of pseudomonas infection in burns by silver sulfadiazine. Surg Gynecol Obstet (1969) 2.53
Defensins. Pharmacol Ther (1995) 2.52
Identification of CRAMP, a cathelin-related antimicrobial peptide expressed in the embryonic and adult mouse. J Biol Chem (1997) 2.38
Human neutrophil defensins selectively chemoattract naive T and immature dendritic cells. J Leukoc Biol (2000) 2.32
Defensins and other endogenous peptide antibiotics of vertebrates. J Leukoc Biol (1995) 2.25
Bactericidal activity of mammalian cathelicidin-derived peptides. Infect Immun (2000) 2.24
Human beta-defensin-2. Int J Biochem Cell Biol (1999) 2.19
Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries. French and Portuguese ICU Study Groups. JAMA (1999) 2.16
Neutrophils and host defense. Ann Intern Med (1988) 1.92
Designer assays for antimicrobial peptides. Disputing the "one-size-fits-all" theory. Methods Mol Biol (1997) 1.79
The skin immune system: progress in cutaneous biology. Immunol Today (1993) 1.76
Antimicrobial peptides as mediators of epithelial host defense. Pediatr Res (1999) 1.57
SMAP-29: a potent antibacterial and antifungal peptide from sheep leukocytes. FEBS Lett (1999) 1.51
Antibiotic peptides from higher eukaryotes: biology and applications. Mol Med Today (1999) 1.44
Costs of treating infections caused by methicillin-resistant staphylococci and vancomycin-resistant enterococci. J Antimicrob Chemother (1999) 1.37
Review of pseudomonas sepsis in thermal burns: verdoglobin determination and gentamicin therapy. Ann Surg (1966) 1.32
Complementary DNA sequence of rabbit CAP18--a unique lipopolysaccharide binding protein. Biochem Biophys Res Commun (1991) 1.30
Gene-encoded peptide antibiotics and the concept of innate immunity: an update review. Scand J Immunol (1998) 1.29
Design of synthetic antimicrobial peptides based on sequence analogy and amphipathicity. Eur J Biochem (1997) 1.28
Orientation and dynamics of an antimicrobial peptide in the lipid bilayer by solid-state NMR spectroscopy. Biophys J (2001) 1.27
The ovine cathelicidin SMAP29 kills ovine respiratory pathogens in vitro and in an ovine model of pulmonary infection. Antimicrob Agents Chemother (2001) 1.22
Endogenous vertebrate antibiotics. Defensins, protegrins, and other cysteine-rich antimicrobial peptides. Ann N Y Acad Sci (1996) 1.22
cDNA sequences of three sheep myeloid cathelicidins. FEBS Lett (1995) 1.20
Antimicrobial peptides: an emerging concept in cutaneous biology. J Invest Dermatol (1998) 1.18
Potassium release, a useful tool for studying antimicrobial peptides. J Microbiol Methods (2002) 1.18
Protegrins: new antibiotics of mammalian origin. Expert Opin Investig Drugs (2000) 1.15
Epidemiological significance of cutaneous, pharyngeal, and digestive tract colonization by multiresistant Acinetobacter baumannii in ICU patients. J Hosp Infect (1997) 1.12
Cathelicidin peptides inhibit multiply antibiotic-resistant pathogens from patients with cystic fibrosis. Antimicrob Agents Chemother (2001) 1.10
Calculation of a new Meeh constant and experimental determination of burn size. Burns (1996) 1.09
Reduced antimicrobial peptide expression in human burn wounds. Burns (1999) 1.04
Effect of ions on antibacterial activity of human beta defensin 2. Microbiol Immunol (2000) 1.01
Human beta defensin is absent in burn blister fluid. Burns (2000) 1.01
Activity of protegrins against yeast-phase Candida albicans. Infect Immun (1998) 1.00
An essential amino acid induces epithelial beta -defensin expression. Proc Natl Acad Sci U S A (2000) 0.98
Role of cell-binding in the antibacterial mechanism of lactoferricin B. J Appl Bacteriol (1993) 0.98
Feasibility of biolistic gene therapy in burns. Shock (2001) 0.96
Changes in the concentrations of extracellular Mg++ and Ca++ down-regulate E-cadherin and up-regulate alpha 2 beta 1 integrin function, activating keratinocyte migration on type I collagen. J Invest Dermatol (1995) 0.90
Burning the largest immune organ. Burns (1995) 0.89
The cathelicidin family of antimicrobial peptide precursors: a component of the oxygen-independent defense mechanisms of neutrophils. Ann N Y Acad Sci (1997) 0.89
CRAMP analogues having potent antibiotic activity against bacterial, fungal, and tumor cells without hemolytic activity. Biochem Biophys Res Commun (2000) 0.87
Multiresistant Pseudomonas aeruginosa outbreak in a pediatric oncology ward related to bath toys. Pediatr Infect Dis J (1998) 0.85
Infectious complications: prevention and strategies for their control. Nurs Clin North Am (1997) 0.80
Emerging issues in antibiotic resistance in blood-borne infections. Am J Respir Crit Care Med (2000) 0.79
Biology of infections of split thickness skin grafts. Am J Surg (1975) 0.78
[Cytotoxic and mitogenic effect of antimicrobial peptides from neutrophils on cultured cells]. Tsitologiia (2000) 0.77
[Infection in burn patients: the problems of pathogenesis, prevention and treatment]. Khirurgiia (Mosk) (1999) 0.77
PTIP associates with MLL3- and MLL4-containing histone H3 lysine 4 methyltransferase complex. J Biol Chem (2007) 4.79
Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort. Hepatology (2005) 3.95
Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma. J Hepatol (2005) 3.18
NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States. Hepatology (2002) 2.96
Guidelines for field triage of injured patients. Recommendations of the National Expert Panel on Field Triage. MMWR Recomm Rep (2009) 2.91
Functional and structural diversity in the Als protein family of Candida albicans. J Biol Chem (2004) 2.77
Sarcopenia and mortality after liver transplantation. J Am Coll Surg (2010) 2.75
Effectiveness of hepatocellular carcinoma surveillance in patients with cirrhosis. Cancer Epidemiol Biomarkers Prev (2012) 2.57
Human α-defensin 6 promotes mucosal innate immunity through self-assembled peptide nanonets. Science (2012) 2.44
Anti-inflammatory apoA-I-mimetic peptides bind oxidized lipids with much higher affinity than human apoA-I. J Lipid Res (2008) 2.27
Carbohydrate-binding molecules inhibit viral fusion and entry by crosslinking membrane glycoproteins. Nat Immunol (2005) 2.24
Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus. Nature (2005) 2.23
The solution structures of the human beta-defensins lead to a better understanding of the potent bactericidal activity of HBD3 against Staphylococcus aureus. J Biol Chem (2001) 2.20
Retrocyclin: a primate peptide that protects cells from infection by T- and M-tropic strains of HIV-1. Proc Natl Acad Sci U S A (2002) 2.14
Antibacterial activity and specificity of the six human {alpha}-defensins. Antimicrob Agents Chemother (2005) 2.11
Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients. Hepatology (2003) 2.05
Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C. Hepatology (2008) 2.02
Body fat composition assessment using analytic morphomics predicts infectious complications after bowel resection in Crohn's disease. Inflamm Bowel Dis (2015) 1.97
Membrane-dependent oligomeric structure and pore formation of a beta-hairpin antimicrobial peptide in lipid bilayers from solid-state NMR. Proc Natl Acad Sci U S A (2006) 1.87
Antimicrobial peptides in animals and their role in host defences. Int J Antimicrob Agents (2003) 1.84
Reawakening retrocyclins: ancestral human defensins active against HIV-1. PLoS Biol (2009) 1.80
Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis C. Gut (2010) 1.78
Morphometric age and surgical risk. J Am Coll Surg (2013) 1.73
Surgical site infection and analytic morphometric assessment of body composition in patients undergoing midline laparotomy. J Am Coll Surg (2011) 1.73
A GSK-3/TSC2/mTOR pathway regulates glucose uptake and GLUT1 glucose transporter expression. Am J Physiol Cell Physiol (2008) 1.70
Retrocyclin, an antiretroviral theta-defensin, is a lectin. J Immunol (2003) 1.69
Analytic morphomics, core muscle size, and surgical outcomes. Ann Surg (2012) 1.65
Risk factors for hepatocellular carcinoma may impair the performance of biomarkers: a comparison of AFP, DCP, and AFP-L3. Cancer Biomark (2007) 1.65
Human alpha- and beta-defensins block multiple steps in herpes simplex virus infection. J Immunol (2006) 1.64
Phosphate-mediated arginine insertion into lipid membranes and pore formation by a cationic membrane peptide from solid-state NMR. J Am Chem Soc (2007) 1.63
Sustained virologic response to therapy of recurrent hepatitis C after liver transplantation is related to early virologic response and dose adherence. Liver Transpl (2007) 1.61
Interaction of antimicrobial peptide protegrin with biomembranes. Proc Natl Acad Sci U S A (2003) 1.61
The N-terminus of hepcidin is essential for its interaction with ferroportin: structure-function study. Blood (2005) 1.60
Theta defensins protect cells from infection by herpes simplex virus by inhibiting viral adhesion and entry. J Virol (2004) 1.58
Solid-state NMR investigation of the depth of insertion of protegrin-1 in lipid bilayers using paramagnetic Mn2+. Biophys J (2003) 1.55
Theta-defensins prevent HIV-1 Env-mediated fusion by binding gp41 and blocking 6-helix bundle formation. J Biol Chem (2006) 1.54
Solid-state NMR investigations of peptide-lipid interaction and orientation of a beta-sheet antimicrobial peptide, protegrin. Biochemistry (2002) 1.54
Fat grafting for thermal injury: current state and future directions. J Burn Care Res (2013) 1.51
Activity of alpha- and theta-defensins against primary isolates of HIV-1. J Immunol (2004) 1.50
Histamine derived from probiotic Lactobacillus reuteri suppresses TNF via modulation of PKA and ERK signaling. PLoS One (2012) 1.50
XIAP Is a copper binding protein deregulated in Wilson's disease and other copper toxicosis disorders. Mol Cell (2006) 1.50
Frailty, core muscle size, and mortality in patients undergoing open abdominal aortic aneurysm repair. J Vasc Surg (2011) 1.47
Patient involvement in healthcare is associated with higher rates of surveillance for hepatocellular carcinoma. J Clin Gastroenterol (2011) 1.46
Induction of group A Streptococcus virulence by a human antimicrobial peptide. Proc Natl Acad Sci U S A (2008) 1.45
Evolution of primate theta-defensins: a serpentine path to a sweet tooth. Peptides (2003) 1.42
Effect of a mass casualty incident: clinical outcomes and hospital charges for casualty patients versus concurrent inpatients. Acad Emerg Med (2012) 1.41
The theta-defensin, retrocyclin, inhibits HIV-1 entry. AIDS Res Hum Retroviruses (2003) 1.40
A novel method for oral delivery of apolipoprotein mimetic peptides synthesized from all L-amino acids. J Lipid Res (2009) 1.37
Dual mechanism of bacterial lethality for a cationic sequence-random copolymer that mimics host-defense antimicrobial peptides. J Mol Biol (2008) 1.37
The cushion effect. J Trauma (2003) 1.34
Cervicovaginal secretions contribute to innate resistance to herpes simplex virus infection. J Infect Dis (2005) 1.29
An essential role for complement C5a in the pathogenesis of septic cardiac dysfunction. J Exp Med (2005) 1.29
Determination of peptide oligomerization in lipid bilayers using 19F spin diffusion NMR. J Am Chem Soc (2005) 1.26
Through the looking glass, mechanistic insights from enantiomeric human defensins. J Biol Chem (2009) 1.25
Retrocyclins kill bacilli and germinating spores of Bacillus anthracis and inactivate anthrax lethal toxin. J Biol Chem (2006) 1.25
RC-101, a retrocyclin-1 analogue with enhanced activity against primary HIV type 1 isolates. AIDS Res Hum Retroviruses (2004) 1.23
Interactions of alpha-, beta-, and theta-defensins with influenza A virus and surfactant protein D. J Immunol (2009) 1.22
Killing of African trypanosomes by antimicrobial peptides. J Infect Dis (2003) 1.21
Early detection of burn induced heterotopic ossification using transcutaneous Raman spectroscopy. Bone (2013) 1.19
The formulated microbicide RC-101 was safe and antivirally active following intravaginal application in pigtailed macaques. PLoS One (2010) 1.19
Emotional distress in chronic hepatitis C patients not receiving antiviral therapy. J Hepatol (2002) 1.19
Effects of guanidinium-phosphate hydrogen bonding on the membrane-bound structure and activity of an arginine-rich membrane peptide from solid-state NMR spectroscopy. Angew Chem Int Ed Engl (2008) 1.19
Solid-state NMR investigation of the selective disruption of lipid membranes by protegrin-1. Biochemistry (2004) 1.18
Potassium release, a useful tool for studying antimicrobial peptides. J Microbiol Methods (2002) 1.18
HIV-1 adapts to a retrocyclin with cationic amino acid substitutions that reduce fusion efficiency of gp41. J Immunol (2006) 1.17
Attenuating burn wound inflammatory signaling reduces systemic inflammation and acute lung injury. J Immunol (2006) 1.16
Roles of arginine and lysine residues in the translocation of a cell-penetrating peptide from (13)C, (31)P, and (19)F solid-state NMR. Biochemistry (2009) 1.15
Impact of single-residue mutations on the structure and function of ovispirin/novispirin antimicrobial peptides. Protein Eng (2002) 1.14
alpha-Defensin inhibits influenza virus replication by cell-mediated mechanism(s). J Infect Dis (2007) 1.14